Researchers at six institutions led by the University of Medicine and Dentistry of New Jersey and Pacific Northwest National Laboratory reported finding 738 unique protein markers in spinal fluid samples collected from 43 CFS patients and compared to samples from 25 neurologic post-treatment Lyme disease patients and 11 healthy control subjects. They were able to distinguish CFS from Lyme disease. Proteins identified in CFS patients only have been linked to Parkinson’s disease and Alzheimer’s. The authors have published the library of proteins identified to facilitate deeper explorations for diagnostic tools and potential therapies. (PLoSONE, Feb. 23, 2011) The Association provided analysis of this study, which garnered attention from “The CBS Evening News” and other news agencies. BioTechniques and Expert Review of Proteomics recently covered this study.